AstraZeneca (AZN) Earnings Date, Estimates & Call Transcripts → Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad) Free AZN Stock Alerts $68.55 +0.19 (+0.28%) (As of 04:00 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateApr. 25Before Market OpensConfirmedActual EPS (Feb. 8) $0.73 Missed By -$0.01 Consensus EPS (Feb. 8) $0.74 Read Call TranscriptListen to Call Get AstraZeneca Earnings AlertsEnter your email address below to receive the latest news and earnings results for AZN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAZN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AZN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> AstraZeneca Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$0.87$0.96$0.92 Q2 20242$0.99$1.01$1.00 Q3 20242$1.05$1.05$1.05 Q4 20242$1.09$1.10$1.10 FY 20248$4.00$4.12$4.06 Q1 20251$1.06$1.06$1.06 Q2 20251$1.14$1.14$1.14 Q3 20251$1.17$1.17$1.17 Q4 20251$1.25$1.25$1.25 FY 20254$4.62$4.62$4.62 Q1 20261$1.20$1.20$1.20 AZN Earnings Date and InformationAstraZeneca last issued its earnings results on February 8th, 2024. The reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.74 by $0.01. The company had revenue of $12.02 billion for the quarter, compared to analysts' expectations of $12.07 billion. Its revenue was up 7.3% on a year-over-year basis. AstraZeneca has generated $1.92 earnings per share over the last year ($1.92 diluted earnings per share) and currently has a price-to-earnings ratio of 35.7. Earnings for AstraZeneca are expected to grow by 15.67% in the coming year, from $4.02 to $4.65 per share. AstraZeneca has confirmed that its next quarterly earnings report will be published on Thursday, April 25th, 2024. Read More AstraZeneca Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 4/25/2024Confirmed)------- 2/8/2024Q4 2023$0.74$0.73($0.01)$1.15$12.07 billion$12.02 billion 11/8/2023Q3 2023$0.84$0.87+$0.03$1.30$11.55 billion$11.49 billion 7/28/2023Q2 2023$0.97$1.08+$0.11$1.57$11.06 billion$11.42 billion4/27/2023Q1 2023$0.86$0.96+$0.10$1.34$10.80 billion$10.88 billion2/9/2023Q4 2022$0.68$0.69+$0.01$1.09$11.40 billion$11.21 billion11/10/2022Q3 2022$0.77$0.84+$0.07$1.15$10.98 billion$10.98 billion Get the Latest News and Ratings for AZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. 11/10/2022Q3 2022$0.77$0.84+$0.07$1.15$10.98 billion$10.98 billion7/29/2022Q2 2022$0.78$0.86+$0.08$1.60$10.44 billion$10.77 billion7/29/2022Q2 2022$0.78$0.86+$0.08$1.60$10.44 billion$10.77 billion4/29/2022Q1 2022$0.86$0.95+$0.09$1.77$11.19 billion$11.39 billion4/29/2022Q1 2022$0.86$0.95+$0.09$1.77$11.19 billion$11.39 billion 4/29/2022Q1 2022$0.86$0.95+$0.09$1.77$10.96 billion$11.39 billion 2/10/2022Q4 2021$0.77$0.84+$0.07$1.79$11.04 billion$12.01 billion2/10/2022Q4 2021$0.77$0.84+$0.07$1.79$11.04 billion$12.01 billion2/10/2022Q4 2021$0.77$0.84+$0.07$1.79$11.06 billion$11.50 billion 11/12/2021Q3 2021$0.63$0.54($0.09)$1.63$9.82 billion$9.87 billion11/12/2021Q3 2021$0.63$0.54($0.09)$1.63$9.82 billion$9.87 billion11/11/2021Q3 2021$0.62$0.54($0.08)$1.63$9.58 billion$9.74 billion 7/29/2021Q2 2021$0.45$0.45-$0.69$7.79 billion$8.22 billion7/29/2021Q2 2021$0.45$0.45-$0.69$7.79 billion$8.22 billion7/28/2021Q2 2021$0.43$0.45+$0.02$0.69$7.79 billion$8.22 billion 4/30/2021Q1 2021$0.71$0.81+$0.10$1.03$7.17 billion$7.32 billion4/30/2021Q1 2021$0.71$0.81+$0.10$1.03$7.17 billion$7.32 billion4/29/2021Q1 2021$0.71$0.82+$0.11$1.03$7.15 billion$7.32 billion AstraZeneca Earnings - Frequently Asked Questions When is AstraZeneca's earnings date? AstraZeneca has confirmed that its next quarterly earnings data will be published on Thursday, April 25th, 2024. Learn more on AZN's earnings history. Did AstraZeneca beat their earnings estimates last quarter? In the previous quarter, AstraZeneca (NASDAQ:AZN) missed the analysts' consensus estimate of $0.74 by $0.01 with a reported earnings per share (EPS) of $0.73. Learn more on analysts' earnings estimate vs. AZN's actual earnings. How can I listen to AstraZeneca's earnings conference call? The conference call for AstraZeneca's latest earnings report can be listened to online. Listen to Conference Call How can I read AstraZeneca's conference call transcript? The conference call transcript for AstraZeneca's latest earnings report can be read online. Read Transcript How much revenue does AstraZeneca generate each year? AstraZeneca (NASDAQ:AZN) has a recorded annual revenue of $45.81 billion. How much profit does AstraZeneca generate each year? AstraZeneca (NASDAQ:AZN) has a recorded net income of $5.96 billion. AZN has generated $1.92 earnings per share over the last four quarters. What is AstraZeneca's price-to-earnings ratio? AstraZeneca (NASDAQ:AZN) has a trailing price-to-earnings ratio of 35.70 and a forward price-to-earnings ratio of 17.05. The price/earnings-to-growth ratio is 1.25. What is AstraZeneca's EPS forecast for next year? AstraZeneca's earnings are expected to grow from $4.02 per share to $4.65 per share in the next year, which is a 15.67% increase. More Earnings Resources from MarketBeat Related Companies: NVS Earnings Results ABT Earnings Results PFE Earnings Results ABBV Earnings Results SNY Earnings Results BMY Earnings Results VRTX Earnings Results REGN Earnings Results MRK Earnings Results GSK Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:AZN) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.